Marcus Muehlbauer MD, PhD

Marcus Mühlbauer, M.D., Ph.D., received his initial clinical and research training at the University of Regensburg, Germany. In 2006, he became interested in researching the role of the microbiome in inflammatory bowel disease; specifically colitis-associated colon cancer. He joined the laboratory of Christian Jobin, Ph.D., at the University of North Carolina in Chapel Hill (UNC) and graduated from UNC’s gastroenterology fellowship program in 2014 specializing in inflammatory bowel disease (Crohn’s disease and ulcerative colitis).

Dr. Muhlbauer joined UF in June 2015 and became the director of the Inflammatory Bowel and Celiac Disease Program in January 2019. He also serves as director of the University of Florida Fecal Microbiota Transplant Program. Dr. Mühlbauer’s primary focus is achieving the highest quality of life for patients suffering from inflammatory bowel disease.